throbber
n
`
`/
`
`finchemistw ‘
`
`
`
`Page 1 of 15
`
`CSL EXHIBIT 1011
`
`CSL V. Shire
`
`CSL EXHIBIT 1011
`CSL v. Shire
`
`Page 1 of 15
`
`

`

`'
`
`
`Subscriptions are available only on a ca n i-
`year basis. (For membershi
`information. --
`tact Office of Membership
`elopment at
`ACS Washington address.)
`New and renewal subscriptions should t'
`sent with pa ment to Business Manag u — ‘
`Division. A 5. PD. Box 57136. West
`'
`Station. Washington. DC. 2003']. Rates "
`not apply to nonmember subscribers in In _
`a'
`who must enter subscription orders with
`ruzen Company Ltd.. 3-10 Nihonhashi
`chome. Chuo-ku. Tokyo 103. Japan. Tel: (
`272-72l I.
`Printed edition single issue prices: cu A.
`year $14.00; prior year $16.00. Back vol

`price: $403.00. Foreign postage addi '
`Mail orders should be sent to Microfornts
`Back Issues Office at the ACS Washin I
`address. Phone orders can be placed for v
`'
`ed. microfiche. and microfilm editions
`- ‘
`ing the ACS Sales Office TOLL FR E
`(800) 424-6747 from anywhere in the n
`nental United States: Washington. D.C.. w
`call (202) 872-8065.
`Phone orders can
`charged to Visa. MasterCard. or A #-
`Express accounts.
`Changes of address must include both i
`and new addresses with ZIP code and I a
`mailing label. Send all address Chan -
`Membership and Subscription Services.
`'
`allow 6 weeks for change to become an“
`Claims for missing numbers will not be
`I
`i
`if loss was due to failure of notice ofc. -‘
`.
`address to be received in the time specil'
`claim is dated (a) North America. more '
`90 days beyond issue date; (b) all other 1"
`7‘
`more than one year beyond issue date: orlf
`reason given is “missing from files". Hard '
`claims are handled by Membership and
`scription Services.
`Supplementary material is noted in the t
`of contents with a I.
`it is available as t
`I
`copy ($6.00 for up to 3 pages and $1.
`page for additional pages. plus $2.00 for f .'
`postage) or as 24X microfiche (56m.
`SLOO for foreign pasta e). Seesu
`-v 7
`material notice at en of jouma a '
`number of pages. Orders must state w .
`for photocopy or microfiche and give -- H
`title of article. names of authors. journal.
`date. and page numbers. Prepayment
`rom Microforms & Back Issues 0 toe
`uired and prices are subject to chanrfe t,’
`ACS Washington address.
`Su
`le
`material also a pears in the micro tlm '
`and may be or ered by subscription (in '
`fiche only).
`Cover:
`Based on a
`subunit—courtesy of Jane
`
`‘
`
`1
`
`‘
`
`hemogl ‘
`. Richa u
`
`Biochemistry (ISSN 0006-2960) is published biweekly by the American Chemical
`Society at 1155 16th Street. N.W.. Washington. DC. 20036. Second-class pot
`paid at Washington, DC. and additional mailing offices. POSTMASTER:
`address changes to Biochemistry. Membership and Subscription Services. PO. Box
`3337. Columbus. Ohio 43210.
`
`"
`
`Books and Journals Division
`D. H. Michael Bowen. Director
`
`JOURNALS
`Charles R. Bertsch. Head; MarianneC.
`Brogan. Associate Head; Mary E.
`Scanlan, Assistant Manager; Deborah
`K. Miller. Supervisory Editor: Beth A.
`Rogers. Ruth A. Linville, and Darrell
`McGeorge. Assistant Editors; Barbara
`1. Taylor, Staff Editor
`RESEARCH AND DEVELOPMENT
`Lorrin R. Carson. Head
`
`Advertising 0%“: Centcom. Ltd.. 258
`Road South.
`estpon. CT 068“.
`
`x
`
`:1-
`-
`
`>
`
`‘
`
`'
`
`NATIONAL
`
`gives
`
`EXPOSITION
`
`10,000 + scientists and
`
`engineers are coming
`to Anaheim in
`
`September .
`
`.
`
`.
`
`And they’ll be looking
`for the latest in
`
`instrumentation,
`
`hardware, software,
`
`chemicals, equipment,
`
`books, journals, and
`
`continuing education.
`
`Will you be there to
`talk business with
`
`them?
`
`Get leads, make
`
`contacts, and
`
`demonstrate your
`
`products at .
`
`.
`
`.
`
`The
`ACS Fall
`Exposition
`in Anaheim
`
`September 8-10, 1986
`
`for information about fl‘\(’l'\ mg hunth
`\piltt‘ Vtrttt' or all lwulyn Fuller .1!
`(2011 3‘}! ms
`
`Amt'ntunt ht‘mlkai \Utlt'l) I (lttitt- n1
`Exposition and hshtblt M‘ruuw ' I I“
`sixteenth .‘lrt't‘l. V \t 0 Washington.
`|)(. limits
`
`American Chemical Society
`1155 l6th Street. NW.
`Washington. DC. 20036
`(202) 872-4600
`[TDD (202) 872-8733]
`
`Membership and Subscription Services
`American Chemical Society
`PO. Box 3337. Columbus. Ohio 43210
`(614) 421-3776
`
`Journals Department
`American Chemical Society
`2540 Olentangy River Road
`PO. Box 3330. Columbus. Ohio 432l0
`(614) 421-3600. ext 3171
`(TELEX 6842086)
`
`© Copyright 1986 by the American Chem-
`ical Society. Copyright permission: An indi-
`vidual may make a single reprographic copy of
`an article in this publication for personal use.
`Reprographic copying beyond that
`rmitted
`by Section 107 or 108 of the U.S.
`opyright
`Law is allowed, provided that the ap ropriate
`per—copy fee is paid through the
`op right
`Clearance Center, Inc.. 27 Congress St..
`lem.
`Massachusetts 01970. For reprint permission.
`ooks and Journals Division. at
`the ACS
`please write to the Copyright Administrator.
`Washington address.
`Editorial Information
`Instructions to authors and copyright status
`form are printed in the first issue of each vol-
`ume. Please conform to these instnrctions when
`submitting manuscripts.
`Manuscripts for publication should be sub-
`mitted to the Editor. Hans Neurath. De art-
`menl of Biochemistry. University of Was ing-
`ton. Seattle. Washington 98195. Correspond-
`ence regarding accepted papers and proofs
`should be directed to the Journals Department
`at the address above. Page charges of $30.00
`per page may be paid for papers ublished in
`this journal. Payment does not a fect accept-
`ance or scheduling of papers. Bulk reprints of
`individual articles are available. For informa-
`tion write to Distribution Office at the ACS
`Washington address.
`The American Chemical Society and its Ed-
`itors assume no responsibility for the statements
`and opinions advanced by contributors.
`Registered names and trademarks. etc.. used
`in this publication. even without specific indi-
`cation thereof. are not to be consi cred unpro-
`tected by law.
`
`Subscription and Business Information
`1986 subscription prices including postage.
`All Other
`Europe Counth
`Air Service Air Service
`Included
`Included
`
`Canada
`and
`US. Mexico
`
`5 65
`$334
`
`3 65
`53!!
`
`S W
`3367
`
`S 63
`833‘
`
`SIM
`$399
`
`S 89
`5351!
`
`$155
`542‘
`
`3 l9
`‘3”
`
`Printed
`Members
`Nonmember!
`Microfiche
`Members
`Nonmember:
`Supplementary
`material
`on miwonche
`
`Page 2 of 15
`
`

`

`BICHAW 25(15) 4175—4472 (1986)
`
`
`
`ISSN 0006-2960
`
`
`Registered in US. Patent and Trademark (We:
`
`
`
`
`
`
`
`Copyright “'86 by the American Chemical Society
`
`
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`
`a biweekly publication of the American Chemical Society
`
`
`
`July 29, 1986
`
`
`
`ACCELERATED PUBLICATIONS
`
`
`
`
`
`Purification of a Protein C Activator from the Venom of the Southern Copperhead Snake (Agkistrodon
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`contortrix contortrix)
`
`
`Janet D. Klein and Frederick J. Walker“
`
`
`
`
`
`
`
`
`ARTICLES
`
`
`N—(6-Phenylhexyl)-S-chloro-l-naphthalenesulfonamide, a Novel Activator of Protein Kinase C
`
`
`
`
`
`
`
`
`Masaaki Ito, Toshio Tanaka. Masaki Inagaki. Koji Nakant‘shi. and Hiroyoshi Hidalca‘
`
`
`
`
`
`
`
`
`
`
`
`
`
`Medium-Chain Aeyl Coenzyme A Dehydrogenase from Pig Kidney Has Intrinsic Enoyl Coenzyme A
`
`
`
`
`
`
`
`
`
`
`
`
`I-Iydratase Activity
`
`
`Sze—Mei Lon, Pat Powell, Hermann Bnettner, Sandro Ghisla, and Colin Thorpe'
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Noncompetitive and Irreversible Inhibition of Xanthine Oxidase by Benzimidazole Analogues Acting at the
`
`
`
`
`
`
`
`
`
`
`
`
`Functional Flavin Adenine Dinucleotide Cofactor
`
`
`
`
`
`Edward B. Skibo
`
`
`
`
`
`
`Crystal Structure of a Novel Trimethoprim-Resistant Dihydrofolate Reductase Specified in Escherichia coli
`
`
`
`
`
`
`
`
`
`
`by R-Plasmid R67
`
`
`
`David A. Motthews.‘ S. L. Smith. D. P. Baccanari. J. J. Burchall. S. J. Outlay, and J. Kraut
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Characterization of Phenylalanine Hydroxylase
`
`
`
`
`L. M. Bloom, S. J. Benkooic,‘ and Betty Jean Gaffney
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`A Spectral Study of Cobalt(II)-Substituted Bacillus cereus Phospholipase C
`
`
`
`
`
`
`
`
`
`Roy Bicknell,‘ Graeme R. Hanson, Barton Holmquist, and Clive Little
`
`
`
`
`
`
`
`
`
`
`
`
`Novel Preparation of Functional Sindbis ViIOSOmes
`
`
`
`
`
`
`Ronald K. Schem‘e
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`fi-Elimination of Indole from L-Tryptophan Catalyzed by Bacterial Tryptophan Synthase: A Comparison between
`
`Reactions Catalyzed by Tryptophanase and Tryptophan Synthase
`
`
`
`
`
`
`
`Syed Ashrafuddin Ahmed, Brian Martin, and Edith Wilson Miler‘
`
`
`
`
`
`
`
`
`
`
`
`Isomerization of (SS)-2.3-Dihydro-5-fluoro-L-tryptophan and of S—Fluoro-L-tryptophan Catalyzed by Tryptophan
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Synthase: Studies Using FluOrine-l9 Nuclear Magnetic Resonance and Difference Spectroscopy
`
`Edith Wilson Miler} Robert S. Phillips. Herman J. C. Yell. and Louis A. Cohen
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Role of Head Group Structure in the Phase Behavior of Amino Phospholipids.
`
`
`
`
`
`
`
`
`
`
`
`Lamellar Phases of Saturated Phosphatidylethanolamine Analogues
`
`
`
`
`
`
`John R. Siluius.‘ Pamela M. Brown. and Timothy J. O’Leary
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`I. Hydrated and Dehydrated
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pamela M. Brown, John Steers, Sek Wen Hui, Philip L. Yeagle, and John R. Siloius"
`
`
`
`
`
`
`
`
`
`
`Chemical Modification of Tyrosine Residues in p-Hydmxybenzoate Hydroxylase from Pseudomonas fluorescens:
`
`
`Assignment in Sequence and Catalytic Involvement
`
`
`
`
`
`
`Robert A. Wijnands, Wicker J. Weijer. Franz Mullen" Peter A. Jekel. Willem J. H. van Berkel,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`and Jeep J. Beintema
`
`
`
`
`
`Role of Head Group Structure in the Phase Behavior of Amino Phospholipids. 2. Lamellar and Nonlamellar
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Phases of Unsaturated Phosphatidylethanolamine Analogues
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 3 of 15
`
`

`

`
`4A BIOCH-aM-ISTRY, VOL. 25, NO.
`
`
`
`
`
`:5,
`
`
`
`I986
`
`
`4268
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Structural Heterogeneity of the a Subunits of the Nicotinic Acetylcholine Receptor in Relation to Agonist
`
`
`
`
`
`
`Affinity Alkylation and Antagonist Binding
`Manohar Ratnam. William Gullick, Joachim Spiess, Kee Wan, Manuel Criaalo, and
`
`
`
`
`
`
`
`
`
`
`Jon Lindstrom“
`
`
`
`
`
`
`
`Structural Characterization of the ATP-Hydrolyzing Portion of the Coated Vesicle Proton Pump
`
`
`
`
`
`
`
`
`
`
`
`Michael Forgoc“ and Michael Bertie
`
`
`
`
`
`
`
`
`Estimated Conformation, Orientation, and Accumulation of Dynorphin A-(l-l3)-tridecapeplide on the Surface of
`
`
`
`
`
`
`
`
`
`
`
`
`Neutral Lipid Membranes
`
`
`
`Robert Schwyzer
`
`
`
`Use of Cytochrome P4150m To Measure CholesteroluLipid Interactions
`
`
`
`
`
`
`
`
`Victoria L. Stevens, J. David tambeth, and Alfred H. Merrill, Jr.‘
`
`
`
`
`
`
`
`
`
`
`
`
`
`Human CI Inhibitor: Primary Structure, cDNA Cloning, and Chromosomal Localization
`
`
`
`
`
`
`
`
`
`
`Susan Clark .Bock.‘K Karen Skrioer. Egon Nielsen, Hans-Christian Thogersert, Bjorn Wiman,
`
`
`
`
`
`
`
`
`
`
`
`Virginia H. Donaldson. Roger L. Eddy. Jean Marriaari, Elzbieta Radziejewska. Robert Huber.
`
`
`
`
`
`
`
`
`
`
`
`Thomas 8. Shows. and Stafian Magnassoa“
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Iron-Containing Metallocenes as Active Site Directed Inhibitors of the Proteinase That Cleaves the
`NHz-Terminal Propeptides from Type I Procoilagen
`
`
`
`
`
`
`Kenneth E. Dombrowslci. John E. Shears, and Darwin J. Prockop"
`
`
`
`
`
`
`
`
`
`
`
`
`
`Amino Acid Sequence of a Basic Agkistrodon holy: blomhofiii Phospholipase A2. Possible Role of
`
`
`
`
`
`
`
`
`
`
`
`
`NHz-Terminal Lysines in Action on Phospholipids of Escherichia coli
`
`
`
`
`
`
`
`
`
`Steven Forst, Jerrold Weiss. Peter Blackburn, Bias FraagiOne. Fernando Gom‘. and Peter Elsbach‘
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Subunit Structure of the Fatty Acid Reductase Complex from Photobacteriam phosphoream
`
`
`
`
`
`
`
`
`
`
`lee Wall and Edward A. Meighen"
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Purification of a Benzo[a]pyrene Binding Protein by Affinity Chromatography and Photoaffinity Labeling
`Sheila Collins and Michael A. Marlena"
`
`
`
`
`
`
`
`
`
`Redox Properties and Mossbauer Spectroscopy of Azotobacter oinelandii Bacterioferritin
`
`
`
`
`
`
`
`
`
`G. D. Watt,‘ R. B. Frankel, G. C. Papaeflhymiou, K. Spartaliaa, and E. I. Stiefel
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Reassignment of the Guanine-Binding Mode of Reduced Mitomycin C
`
`
`
`
`
`
`
`
`
`Maria Tomasz.' Roselyn Lipman, Gregory L. Verdiae. and Kojt' Nakanishi“
`
`
`
`
`
`
`
`
`
`
`
`
`Production of Dihydrothymidine Stereoisomers in DNA by y-Irradiation
`
`
`
`
`
`
`
`
`Eileen A. Furlong, Timothy J. Jorgensert, and William D. Henner"
`
`
`
`
`
`
`
`
`
`
`
`Nucleotide Sequence Binding Preferences of Nogalamycin Investigated by DNase I Footprinting
`
`
`
`
`
`
`
`
`
`Keith R. Fox‘ and Michael J. Waring
`
`
`
`
`
`
`
`
`
`
`Isolation of a Multifunctional Protein with Aminoimidazole Ribonucleotide Synthetase. Glycinamide
`
`
`
`
`
`
`
`
`
`Ribonucleotide Synthetase. and Glycinamide Ribonucleotide Transformylase Activities: Characterization of
`
`
`
`
`
`
`
`
`Aminoimidazole Ribonucleotide Synthetase
`
`
`
`J. L. Schrimsher, F. J. Schendel. and J. Stubbe“
`
`
`
`
`
`
`
`
`
`
`
`
`
`Purification and Characterization of Aminoimidazole Ribonucleotide Synthetase from Escherichia coli
`
`
`
`
`
`
`
`
`
`J. L. Schrimsher, F. J. Schendel, J. Stubbe,‘ and J. M. Smith
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Covalent Modification of the Inhibitor Binding Site(s) of Escherichia coli ADP-Glucose Synthetase: Specific
`
`
`
`
`
`
`
`
`
`
`
`
`
`Incorporation of the Photoaffinity Analogue B-Azidoadenosine S’-Monophosphate
`
`
`
`
`
`
`
`Charles E. Larsen and Jack Preirs’
`
`
`
`
`
`
`
`Partial Reversal of a2u Globulin Gene Expression by Thyroxine in the Liver of Diabetic Rats
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`C. V. Ramona Murry, William F. Demyaa. Baadana Chatterjee. and Ann: K. Roy“
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Alteration of Intramolecular Disulfides in Insulin Receptor/Kinase by Insulin and Dithiothreitol:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Potentiates the Apparent DithiothreitoI-Dependent Subunit Reduction of Insulin Receptor
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Peter A. Wilden, Timothy R. Boyle, Michael L. Swanson, laurel J. Sweet, and Jeffrey E. Pessia'
`
`Insulin
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Biochemical Signal Transmitted by Fc Receptor for Immunoglobulin G2,, of a Murine Macrophage-like Cell Line.
`
`
`
`
`
`
`
`
`
`
`
`P388Dl: Mode of Activation of Adenylate Cyclase Mediated by Immunoglobulin Gh Binding Proteins
`
`
`Rafael Fernandez-Botran and Truneo Suzuki‘
`
`
`
`
`
`
`Raphael Zia‘overzki. Marry Bartholdi, Donna Arndt- Jooin, and Thomas M. Josie“
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Rotational Dynamics of the Fc Receptor for Immunoglobulin E on Histamine-Releasing Rat
`
`
`
`
`
`
`
`
`
`
`Basophilic Leukemia Cells
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 4 of 15
`
`

`

`BIOCHEMISTRY, VOL. 25, N0. 15, 1986
`
`SA
`
`.I
`
`.
`
`Ca2+ Binding to Chromaffin Vesicle Matrix Proteins: Effect of pH, Mg“, and Ionic Strength
`Felicitas U. Retffen and Manfred Gratzl‘
`
`Apolipoprotein C-III/Sphingomyelin Recombinants: Formation, Isolation, and Characterization
`Tareq Y. Ahmad. John R. Guyton. James T. Sparrow. and Joel D. Morrisett“
`
`X
`
`Human Lysosomal Sphingomyelinase: Substrate Efficacy of Apolipoprotein/Sphingomyelin Complexes
`Tareq Y. Ahmad, Arthur L. Beaudet. James T. Sparrow, and Joel D. Morrisett’
`
`Alternative Carbon Monoxide Binding Modes for Horseradish Peroxidase Studied by Resonance
`Raman Spectroscopy
`Ruby Euangelista-Kirkup, Giulietta Smulevich, and Thomas G. Spiro‘l
`
`Raman and Infrared Spectra of Cytochrome c Peroxidase-Carbon Monoxide Adducts in Alternative
`Conformational States
`
`Giulietta Smulevich, Ruby Evangelista-Kirkup, Ann English, and Thomas G. Spiro‘
`
`Identification of Amino Acid Residues Photolabeled with 2-Azido[a-”P]adenosine Diphosphate in the [3 Subunit
`of Beef Heart Mitochondrial Fl-ATPase
`Jérome Garin,‘ Franqois Boulay, Jean Paul Issartel, Joel Lunardi. and Pierre V. Vignais
`
`Menadione- (2-Methyl-l,4-naphthoquinone-) Dependent Enzymatic Redox Cycling and Calcium Release
`by Mitochondria
`Balz Frei, Kaspar H. Winterhalter, and Christoph Richter’
`
`Chromatographic Analysis of the Chiral and Covalent Instability of S-Adenosyl-L-methionine
`Jerald L. Hoffman
`
`Study of the Interaction of Escherichia coli Methionyl-tRNA Synthetase with tRNA’Met Using Chemical and
`Enzymatic Probes
`Heike Pelka and LaDonne H. Schulman‘
`
`Binding of N-Acetylgalactosamine-Specific Lectins to Spin-Labeled Galactosamine Derivatives
`Lawrence J. Berliner.‘ Giovanni Musci. Mary Maliarik. Nike R. Plea-sax. and Irwin J. Goldstein
`
`Kinetic Comparison of Ricin Immunotoxins: Biricin Conjugate Has Potentiated Cytotoxicity
`Jon W. Marsh‘ and David M. Neville. Jr.
`
`Telephone toll free 800-424-6747.
`
`Surface Properties of l.2-Dipalmitoyl-3-acyl-sn-glycerols
`David A. Fahey and Donald M. Small‘
`
`There is no supplementary material for this issue.
`
`‘ In papers with more than one author, the asterisk indicates the name of the author to
`whom inquiries about the paper should be addressed.
`
`This publication is available in
`four formats:
`
`online 0 microfilm o microfiche 0 print
`
`For more information, contact your information specialist, or
`
`American Chemical Society, Sales Office, 1155 Sixteenth Street, NW, Washington, DC 20036.
`
`Page 5 of 15
`
`

`

`4292
`
`
`
`Biochemistry 1986, 25, 4292-4301
`
`
`
`
`
`
`Tschesche, R., & Wolff, G. (1963) Tetrahedron 19, 621—934.
`
`
`
`
`
`
`
`
`
`Vandenbeuvel, F. A. (1963) J. Am. 0i! Chem. Soc. 40,
`
`
`
`
`
`
`
`
`
`
`455—471.
`
`van Dijek, P. W. M. (1979) Biochim. Biophys. Add 555,
`
`
`
`
`
`
`
`
`
`89—101.
`
`van Dijck, P. W. M., DeKruijff, B., van Deenen, L. L. M.,
`
`
`
`
`
`
`
`
`
`
`
`De Gier, J ., & Demo], R. A. (1976) Biochim. Biophys. Acid
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`455, 576—587.
`
`
`Wattenberg, B. W., & Silbert, D. F. (1983) J. Biol. Chem.
`
`
`
`
`
`
`
`
`
`
`258, 2284-2289.
`
`
`Yeaglc, P. L.. Hutton. W. C., Huang, C., & Martin, R. B.
`
`
`
`
`
`
`
`
`
`
`
`
`(1975) Proc. Natl. Acad. Sci. U.S.A. 72, 34774481.
`
`
`
`
`
`
`
`
`Yedgar, S., Barenholz, Y., & Cooper, V. G. (1974) Dion-him.
`
`
`
`
`
`
`
`
`
`
`Biophys. Acio 363, 98—111.
`
`
`
`
`
`
`
`Human Ci Inhibitor: Primary Structure, cDNA Cloning, and Chromosomal
`
`
`
`
`
`
`
`
`
`Localizationl
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Susan Clark Bock,” Karen Skriver,i Egon Nielsen,g Hans-Christian Thogersen,” Bjorn Wiman,‘
`
`
`
`
`
`
`
`
`
`
`
`
`Virginia H. Donaldson} Roger L. Eddy,V Jean Marrinan,1 Elzbieta Radziejewska.t Robert Huber,o
`
`
`
`
`
`
`Thomas B. Shows,v and Staffan Magnusson "i
`The Rockefeller University. New York, New York 10021. Department of Molecular Biology. University of Aarhus. Bit-8000.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Aarhus C, Denmark. Department of Clinical Chemistry, Karolinska Hospital, S-l040l Stockholm, Sweden, Children's Hospital
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Research Foundation, Cincinnati, Ohio 45229, Roswell Park Memorial Institute, Buflol’o. New York 14263, and
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Max—Plonck-lnsritur fuer Biochemie, 8033 Martinsried. FRG
`
`
`
`
`
`
`Received April H, 1986: Revised Manuscript Received May 8. 1986
`
`
`
`
`
`
`
`
`
`
`
`
`0006-2960 86 0425-4292$01.50 0 © 1986 American Chemical Societ
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ABSTRACT: The primary structure of human C1 inhibitor was determined by peptide and DNA sequencing.
`
`The single-chain polypeptide moiety of the intact inhibitor is 478 residues (52 869 Da), accounting for only
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51% of the apparent molecular mass of the circulating protein (104 000 Da). The positions of six gluco-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`samine-based and five galactosamine-based oligosaccharides were determined. Another nine threonine rmidues
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`are probably also glycosylated. Most of the carbohydrate prosthetic groups (probably 1'!) are located at
`the amino-terminal end (residues l—120) of the protein and are particularly concentrated in a region where
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`the tetrapeptide sequence Glx-Pro-Thr-Thr, and variants thereof, is repeated 7 times. No phosphate was
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`detected in C1 inhibitor. Two disulfide bridges connect cysteine-101 to cysteine—406 and cysteine-108 to
`cysteine-183. Comparison of the amino acid and cDNA sequences indicates that secretion is mediated by
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`a 22—residue signal peptide and that further proteolytic processing does not occur. Cl inhibitor is a member
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`of the large serine protease inhibitor (serpin) gene family. The homology concerns residues 120 through
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`the C-tertninus. The sequence was compared with those of nine other scrpins, and conserved and nonoonserved
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`regions correlated with elements in the tertiary structure of al-antitrypsin. The C1 inhibitor gene maps
`to chromosome 1 1, pl 1.2-q13. C1 inhibitor genes of patients from four hereditary angioneurotic edema
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`kindreds do not have obvious deletions or rearrangements in the Cl inhibitor locus. A HgiAI DNA
`polymorphism, identified following the observation of sequence variants, will be useful as a linkage marker
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`in studies of mutant Cl inhibitor genes.
`
`
`Ci inhibitor is a highly glycosylated 104 000-13211 plasma
`
`
`
`
`
`
`protease inhibitor that can inhibit components of the com-
`
`
`
`
`
`
`
`
`plement, coagulation, fibrinolytic. and kinin-releasing systems.
`
`
`
`
`
`
`
`It was first purified in 1961 (Pensky ct 9.1., 1961) and later
`
`
`
`
`
`
`
`
`
`
`
`(Penalty 8r. Schwick, 1969) found to be immunologically
`
`
`
`
`
`
`
`
`identical with a previously characterized aZ-neuramino-
`
`
`
`
`
`glycoprotein (Schultze et al., 1962). CT inhibitor has been
`
`
`
`
`
`
`
`
`
`shown to inhibit macromolecular C1, the Cls and Clr sub-
`
`
`
`
`
`
`
`
`
`
`
`
`fThis work was supported by USPHS Grants HL-l5690 (V.H.D.),
`
`
`
`
`
`
`
`
`
`
`HL-lfilSS (SAIL), HL-307I2 (S.C.B.), and FIB-05196 and Gilli-20454
`
`
`
`
`
`
`
`
`(T.B.S.) and funds from the Danish Science and Medical Research
`
`
`
`
`
`
`
`
`
`
`Councils (S.M.), the Danish Cancer Society (SM. and KS), and the.
`
`
`
`
`
`
`
`
`
`
`
`American Heart Association (83-1202, S.C.B.).
`
`
`
`
`
`‘ Correspondence should be addressed to these authors.
`
`
`
`
`
`
`
`3The Rookel'eller University.
`
`
`
`IUniversity of Aarhus.
`
`
`
`
`lPresent address: MRC Laboratory of Molecular Biology. Cam-
`
`
`
`
`
`
`
`
`bridge, England CBZ 20H.
`
`
`
`
`‘- Karolinska Hospital.
`
`
`
`*Children‘s Hospital Research Foundation.
`
`
`
`
`“Roswell Park Memorial Institute.
`
`
`
`
`
`"Max-Planck-Institul flier Biochemie.
`
`
`
`
`
`
`
`
`
`components of the first component of complement (Ratnoff
`
`
`
`
`
`
`
`
`& Lepow, 1957; Levy & Lepow, 1959; Lepow & Leon, 1962:
`
`
`
`
`
`
`
`
`
`
`
`Gigli et 3]., 1968; Pensky et al., 1961; Ratnoff et al., 1969).
`
`
`
`
`
`
`
`
`
`
`
`
`factors X1121 and X13 (Forbes et a1., 1970), plasma kaliikrein
`
`
`
`
`
`
`
`
`
`
`(Ramoff et al., 1969: Giin et al., 1970), and plasmin (Ratnoff
`
`
`
`
`
`
`
`
`
`
`
`ct 8.1., 1969). Like other serine protease inhibitors [serpins
`
`
`
`
`
`
`
`
`
`(Carroll, 1984)] of the antithrombin III-al-antitrypsin family
`
`
`
`
`
`
`
`(Petersen et 31., 1979), C1 inhibitor reacts with target proteases
`
`
`
`
`
`
`
`
`
`
`to form proteolytically inactive, stoichiometric 1:1 complexw
`
`
`
`
`
`
`
`that are stable during NaDodSO4—PAGE (Harpel & Cooper.
`
`
`
`
`
`
`
`
`1975; Sim et al., 1979; Sim et al., 1980) under reducing
`
`
`
`
`
`
`
`
`
`
`
`conditions (Nilsson et al., 1983). To improve understanding
`
`
`
`
`
`
`
`
`of how Ci inhibitor regulates diverse plasma scrine proteases.
`
`
`
`
`
`
`
`
`
`we have determined its sequence and covalent structure. To
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`address questions concerning the evolution and structure of
`
`
`
`‘ Abbreviations: bp. base pairs; kb, kilobase; Da, dalton; serpin. serine
`
`
`
`
`
`
`
`
`
`
`
`protease inhibitor; NaDodSO.. Sodium dodecyl sulfate: PAGE. I301!"
`
`
`
`
`
`
`
`acrylamide gel electrophoresis; HANE, hereditary angioneurotic edema:
`
`
`
`
`
`
`
`
`A, angstrom; DNS, S-(dimethylamino)naphthalenesulfonyl; RFLP. rc-
`
`
`
`
`slriction fragment length polymorphism; HPLC, high-performance lin-Ild
`
`
`
`
`
`
`
`chromatography: PTH, phenylthiohydantoin.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 6 of 15
`
`

`

`" imam c-i INHIBITOR
`
`
`
`
`
`VOL. 25, no. 1-5, was
`
`
`
`
`
`
`
`
`
`
`
`
`'4293
`
`
`
`
`
`
`
`
`
`
`
`
`
`-_
`, we compared the Cl inhibitor sequence with those of
`nine other family members.
`
`
`
`
`Cl inhibitor deficiency is inherited as an autosomal dom-
`
`
`
`
`
`
`
`
`inant trait in hereditary angioneurotic edema (HANE) which
`
`
`
`
`
`
`
`
`is associated with bouts of localized, increased vascular
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`permeability (Donaldson & Evans, 1963). Although all
`
`
`
`
`
`
`
`
`
`persons with HANE are deficient in C1 inhibitor function,
`the molecular defects are heterogeneous (Rosen et al., 1971;
`
`
`
`
`
`
`
`
`
`Donaldson et al., 1985).
`in order to understand the genetic
`
`
`
`
`
`
`
`
`
`
`lesions responsible for hereditary angionwrotic edema, we have
`
`
`
`
`
`
`
`
`isolated a full length Cl inhibitor cDNA, mapped the Cl
`
`
`
`
`
`
`
`
`
`
`inhibitor locus to human chromosome 11, p11.2-ql3. and
`
`
`
`
`
`
`
`
`
`initiated studies on normal and abnormal C1 inhibitor genes.
`
`
`
`
`
`
`
`
`
`
`MATERIALS AND METHODS
`
`
`
`
`
`
`
`
`Protein Purification. Cl inhibitor was isolated from human
`
`
`
`
`
`
`
`plasma by precipitatiou with poly(ethylene glycol), chroma-
`
`
`
`
`
`
`tography on DEAE-cellulose and hexyl-Sepharose (Nilsson
`
`
`
`
`
`
`& Wiman, 1982). and gel filtration in 0.1 M NH4HC03, pH
`
`
`
`
`
`
`
`
`
`
`
`8.3, on Sepharose 6B. The resulting single-chain material was
`
`
`
`
`
`
`
`
`
`fully active against Cls (Chapuis et al., 1977) and migrated
`
`
`
`
`
`
`
`
`
`
`with an apparent molecular mass of 105000 Da in NaDod-
`
`
`
`
`
`
`
`
`
`SOrPAGE. Phosphate was determined by a modified
`
`
`
`
`
`
`Fiske—Subbarow method (Arnes, 1966). The activation pep-
`
`
`
`
`
`
`tide was separated from the Cls—Cl inhibitor complex by gel
`
`
`
`
`
`
`
`
`
`
`filtration on Sephacryl 5—300 in 40 mM sodium phosphate,
`
`
`
`
`
`
`
`
`
`0.1 M NaCl, 0.1 M NaNJ, and 0.1% NaDodSO4, pH 7.3.
`
`
`
`
`
`
`
`
`
`
`
`Amino Acid Sequencing. Cl inhibitor was degraded
`
`
`
`
`
`
`
`chemically or enzymaticaily as indicated in Figure 1a. For
`
`
`
`
`
`
`
`
`
`digestion with pepsin, the protein was dissolved in 99% formic
`
`
`
`
`
`
`
`
`
`
`acid and then diluted to 5%; the enzyme]substrate ratio was
`
`
`
`
`
`
`
`
`
`
`1/ 100 w/w, and the digest was incubated at room temperature
`
`
`
`
`
`
`
`
`
`
`for 3 h. Carbohydrate-rich peptides were treated with tri-
`
`
`
`
`
`
`
`
`fluoromethanesulfonic acid (Edge et al., 1981) or alkaline
`
`
`
`
`
`
`
`
`sodium borohydride (Spiro & Bhoyroe, 1974). Peptides were
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`purified by an initial gel filtration on Sephadex G-SDF or
`Sephacryl 5-200, mostly in 0.1 M NH4HC03, followed by
`
`
`
`
`
`
`
`
`
`ion-exchange chromatography on DEAE-Sephacel using a.
`
`
`
`
`
`
`linear gradient of 001—1 .0 M NH4HC03. Final purification
`
`
`
`
`
`
`
`was achieved by reversed-phase HPLC on a Hewlett-Packard
`
`
`
`
`
`
`
`
`1084B liquid chromatograph. Peptides were sequenced on an
`
`
`
`
`
`
`
`
`Applied Biosystems Model 470A (using the chemicals and the
`
`
`
`
`
`
`
`
`
`02:1 vac program supplied by the manufacturer) or on a
`
`
`
`
`
`
`
`
`
`
`Bookman 890C sequenator. Amino acid analysis was per-
`
`
`
`
`
`
`
`formed on a Beckman 121MB instrument.
`In addition to the
`
`
`
`
`
`
`
`
`
`systems commonly used in our laboratory (Skorstengaard et
`
`
`
`
`
`
`
`
`81., 1982, 1984), columns of Vydac C4 (with elution gradients
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`of 2-propanol and triethylamine, pH 5.2, in 0.1% CF3COOH)
`were also employed for HPLC of peptides and glycopeptides.
`
`
`
`
`
`
`
`
`
`Carbohydrate Determination. N-Glyoosylated Asn residues
`
`
`
`
`
`were assigned when the PTH derivative was obtained in much
`
`
`
`
`
`
`
`
`
`
`less than normal yield and the presence of aspartic acid and
`
`
`
`
`
`
`
`
`
`
`
`a ninhydrin-positive glucosamine peak (eluting near isoleucine
`
`
`
`
`
`
`
`and leucine) was observed in the amino acid chromatogram.
`
`
`
`
`
`
`
`
`
`In addition, Asn residues 59, 216, and 231 were also identified
`
`
`
`
`
`
`
`
`
`
`
`as DNS-Asp in “full” yield when the DNS—Edrnan sequencing
`
`
`
`
`
`
`
`
`
`method was used (Gray, 1967). O-Glycosylated threonine or
`
`
`
`
`
`
`
`
`serine residues were assigned on the corresponding combined
`
`
`
`
`
`
`
`
`criteria of low yield (or no yield) of PTH derivatives and the
`
`
`
`
`
`
`
`
`
`
`
`
`presence of galactosamine and threonine or serine in the hy-
`
`
`
`
`
`
`
`
`
`drolysate.
`
`CDNA Clone Isolation. The initial positive clone, 337, was
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`isolated from a hgtll (Young 3: Davis. 1983) human liver
`
`
`
`
`
`
`
`
`
`
`
`
`' cDNA expression library kindly provided by Drs. S. L. C. Woo
`
`
`
`
`
`
`
`
`
`
`and T. Chandra. This library was screened with (1) goat
`
`inhibitor.
`
`
`
`
`
`
`
`
`anti-human Cl inhibitor serum preabsorbed with hereditary
`angioneurotic edema serum (which was essentially devoid of
`
`
`
`
`
`
`
`
`Cl inhibitor antigens) and (2) rabbit anti-human C1 inhibitor
`
`
`
`
`
`
`
`
`
`serum preabsorbed with human serum albumin. Positive phage
`
`
`
`
`
`
`
`
`were detected by using biotinylated second antibodies and
`
`
`
`
`
`
`
`
`I25I—streptavidin. A29a, 313p, and RIOq (Figure 1c) Were
`
`
`
`
`
`
`
`
`identified by hybridization with the 5’ £37 EcoRI fragment
`
`
`
`
`
`
`
`
`
`and a pool of 96 17-base oligonucleotides encoding the hex—
`
`
`
`
`
`
`
`
`apeptide Met-Leu-PheVaI-Glu—Pro (Harrison, 1983). hSq,
`
`
`
`
`
`h2r, and Mr were obtained by again screening the library, this
`
`
`
`
`
`
`
`
`
`
`
`time with the oligonucleotide dGTCAGCAGGGTCAGCC,
`
`
`
`
`
`which had been identified at the 5' end of clone )tIOq on the
`
`
`
`
`
`
`
`
`
`
`
`
`
`noncoding strand. Sequence analysis showed that ASq, Mr,
`
`
`
`
`
`
`
`
`and Mr contain sequences at their 5’ ends (thick lines) that
`
`
`
`
`
`
`
`
`
`
`
`correspond to sequences from elsewhere in the CT inhibitor
`
`
`
`
`
`
`
`
`
`
`cDNA and that are in inverted repeat orientation to them.
`
`
`
`
`
`
`
`
`
`This artifact of cDNA cloning occurs occasionally for full-
`
`
`
`
`
`
`
`
`length cDNAs (Weaver et al., 1981). The cDNA clone pKll
`
`
`
`
`
`
`
`
`
`
`was obtained from a pUC expression library (Helfman ct al.,
`
`
`
`
`
`
`
`
`
`
`1983) synthesized from HepG2 (Knowles et al., 1980) poly-
`
`
`
`
`
`
`
`
`(A)+ RNA and codes for a valine as residue 458.
`
`
`
`
`
`
`
`
`
`
`DNA Sequencing Strategy. Fragments of the cDNA clones
`
`
`
`
`
`
`
`
`shown in Figure lc were subcloned into pUC plasmids, and
`
`
`
`
`
`
`
`
`
`
`sequence was obtained from linearized double-stranded DNA
`
`
`
`
`
`
`
`
`by the dideoxy method (Sanger et al., I977). Most of the
`
`
`
`
`
`
`
`
`
`
`
`cDNA was sequenced in both directions (Figure 1d): solid
`
`
`
`
`
`
`
`
`
`amino acid sequence data was available for regions where it
`
`
`
`
`
`
`
`
`
`
`was determined on only one strand.
`
`
`
`
`
`
`Serpin Alignment. The alignment was obtained by visual
`
`
`
`
`
`
`
`
`inspection of the mature protein sequences with due consid-
`
`
`
`
`
`
`
`
`eration of already published comparisons (Petersen et at, 1979;
`
`
`
`
`
`
`
`
`
`Hunt & Dayhoff, 1980; Carrel] et al., 1982; Doolittle, 1983,
`
`
`
`
`
`
`
`
`
`
`1985; Hill et al., 1984; Hejgaard et al., 1985; Ragg. 1986).
`
`
`
`
`
`
`
`
`
`
`
`Genomic DNA and Southern Blot Preparation. The
`
`
`
`
`
`
`
`methods that were used for extracting genomic DNA from
`
`
`
`
`
`
`
`
`
`peripheral blood samples of normals and HANE patients and
`
`
`
`
`
`
`
`
`
`for preparing Southern blots have been described previously
`
`
`
`
`
`
`
`
`(Bock et al.. 1985a).
`
`
`
`
`Chromosomal localization. Southern blots containing
`
`
`
`
`BomHI-digested DNA from 41 different human—mouse hy-
`
`
`
`
`
`
`brids were hybridized with the human Cl inhibitor cDNA
`
`
`
`
`
`
`
`
`probe and scored for the presence or absence of 4- and 6-kb
`
`
`
`
`
`
`
`
`
`
`bands present in the human Ci inhibitor gene. The cell by-
`
`
`
`
`
`
`
`
`
`
`brids were generated from 15 unrelated human cell lines and
`
`
`
`
`
`
`
`
`
`
`4 mouse cell lines (Shows et al., 1982, 1984) and have been
`
`
`
`
`
`
`
`
`
`
`
`
`characterized by chromosome analysis and mapped enzyme
`
`
`
`
`
`
`
`markers and partly by mapped DNA probes (Shows et al.,
`
`
`
`
`
`
`
`
`
`
`1978, 1982; Shows, i983).
`
`
`
`
`RESULTS
`
`Primary Structure. The

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket